MicroPort CardioFlow Medtech (HKSE:02160) Days Sales Outstanding : 118.94 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Days Sales Outstanding?

MicroPort CardioFlow Medtech's average Accounts Receivable for the six months ended in Dec. 2023 was HK$113.9 Mil. MicroPort CardioFlow Medtech's Revenue for the six months ended in Dec. 2023 was HK$174.8 Mil. Hence, MicroPort CardioFlow Medtech's Days Sales Outstanding for the six months ended in Dec. 2023 was 118.94.

The historical rank and industry rank for MicroPort CardioFlow Medtech's Days Sales Outstanding or its related term are showing as below:

HKSE:02160' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.38 Med: 77.21 Max: 95.74
Current: 93.75

During the past 6 years, MicroPort CardioFlow Medtech's highest Days Sales Outstanding was 95.74. The lowest was 16.38. And the median was 77.21.

HKSE:02160's Days Sales Outstanding is ranked worse than
76.11% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 65.015 vs HKSE:02160: 93.75

MicroPort CardioFlow Medtech's Days Sales Outstanding increased from Dec. 2022 (101.06) to Dec. 2023 (118.94).

MicroPort CardioFlow Medtech Days Sales Outstanding Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Days Sales Outstanding Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

16.38

72.00

95.74

82.41

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					78.14	119.79	101.06	81.76	118.94

Competitive Comparison of MicroPort CardioFlow Medtech's Days Sales Outstanding

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort CardioFlow Medtech's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Days Sales Outstanding falls into.

MicroPort CardioFlow Medtech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

MicroPort CardioFlow Medtech's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (55.584	+	110.468)	/	2 )	/	367.745	*	365
=	83.026					/	367.745	*	365
=	82.41

MicroPort CardioFlow Medtech's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (117.324	+	110.468)	/	2 )	/	174.756	*	365 / 2
=	113.896					/	174.756	*	365 / 2
=	118.94

MicroPort CardioFlow Medtech (HKSE:02160) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

MicroPort CardioFlow Medtech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines